Institut National de la Statistique, Ministère de la Planification, de la Programmation du Développement et de l’Aménagement du Territoire [Cameroon] and ORC Macro., Minnesota Population Center
422) What medication did you take? Other medication?
RECORD ALL MENTIONED. IF TYPE OF MEDICATION IS NOT DETERMINED, SHOW TYPICAL ANTIMALARIAL DRUGS TO RESPONDENT.
(RESPONSE SET FOR MOST RECENT BIRTH)
AMODIAQUINE/FLAVOQUINE/CAMOQUIN A
FANSIDAR/MALOXINE B
CHLOROQUINE/NIVAQUINE C
QUININE/QUINIMAX D
UNKNOWN DRUG E
OTHER (SPECIFY): ___ X
(RESPONSE SET FOR OTHER BIRTHS)
SP/FANSIDAR A
CHLOROQUINE B
OTHER (SPECIFY): ___ X
DON'T KNOW Z
Categories
Value
Category
0
No
1
Yes
7
Don't know
8
Missing
9
NIU (not in universe)
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Description
Definition
ANMALSP (M49A) indicates whether the child's mother took the antimalarial drug sulfadoxine/pyrimethamine (SP), also known as Fansidar, while the child was in utero. Other common trade names include Maloxine, Malafan, Metakelfin (sulphamethoxypyrazine/pyrimethamine), Novidar, and Amalar.